adplus-dvertising
Connect with us

Economy

Blue economy – The ocean… land of innovation – Investors' Corner – Investors' Corner BNP Paribas

Published

 on


The seas and oceans are fertile ground for innovation and experimentation, with new technologies including:

  • Maritime operations at ever-greater depths
  • Robotics
  • Video surveillance
  • Submersible technologies.

Technological progress has been spectacular. In general, the open location of ports and coastal communities is conducive to the emergence of new ideas. Achieving environmental goals is a constant source of innovation.

Biotechnologies

The oceans are a goldmine for biotechnologies. Maritime resources can be used

  • In cosmetics (creams, seawater therapy, etc.)
  • For the agri-foods industry (food supplements, fertilisers, etc.)
  • In the energy sector (notably biofuels)
  • In pharmacology.

It is possible to create substances derived from algae for food and cosmetics uses. In addition, scientists have discovered that ingredients from oysters can slow skin ageing. The production of biofuels from the triglycerides contained in algae is another potential area of interest.

Lithium

Seawater is a virtually unlimited source of lithium, with the seas and oceans containing some 230 billion tonnes of it.[1] However, lithium is highly diluted in seawater.

Researchers have been working for years to extract it using evaporation or filtering membranes. They have already managed to do so in small quantities. Lithium is used in the glass and ceramics industries, to produce lubricant greases and in aluminium production. It is also essential in making electric batteries.

Energy

The enormous energy in tides, swells and waves is already being tapped. However, this is just the beginning. Innovative technologies will complement the systems already developed.

Source: https://ec.europa.eu/jrc/en/news/new-technologies-ocean-energy-sector

The most favourable coasts are those between the latitudes of 30° and 60°

  • In the southern hemisphere due to the wave heights
  • In the northern hemisphere due to the length of the coasts in question.

The Bay of Fundy’s tidal power station between Nova Scotia and New Brunswick in Canada and the one in the bay of Mont Saint-Michel in France were pioneers in the field. In addition to tidal power stations, systems using energy from waves and tidal currents (underwater turbines and wave power systems) are also being developed.

The European Union, already quite advanced in the field of ocean power technology, should be producing 35% of its electricity from ocean sources by 2050.[2] Reducing the cost of technologies generating wind power is one of the main projects on which the most innovative blue economy players are working.

Pharmaceuticals

The ability of marine organisms other than fish and shellfish to contribute to the blue economy is beginning to be acknowledged thanks to the new gene sequencing technologies for living organisms. Tests of antiviral medicines obtained from nucleotides isolated from Caribbean sponges are already under way. That’s how high the stakes are!

The oceans are a gigantic pharmacy. Marine species are providing the pharmaceutical industry with a wide range of new compounds that have already led to major applications in the antiviral field, but also in cancer and pain treatment medicines.

The animal, plant and bacterial species living in the oceans contain impressive numbers of compounds with unexpected properties that are of interest from a medical standpoint. Some are already known such as those from ‘cone snails’ – gastropod molluscs.

These cousins of land snails secrete neurotoxins. Researchers have been working with them since the 1960s. Cone snails have enabled the development of a compound used in a powerful pain medicine that is stronger than morphine. Researchers are currently working on developing new medicines from cone snail compounds.

Anti-cancer agents are being produced from marine organisms. An anti-tumour medicine has been developed from small marine invertebrates. The most promising medicines already come from the oceans. They have been on pharmacy shelves and have been improving our health for several years now. The research on marine organisms being conducted around the world should continue to unveil new therapeutic properties.

A flourishing sustainable blue economy

Innovation is an essential factor in ensuring that a sustainable blue economy can flourish. Blue technologies hold great promise for established and start-up companies researching and developing solutions that have a positive impact on the oceans.

As a global sustainability theme, investing in the blue economy is fully aligned with BNP Paris Asset Management’s sustainable investment priorities. These are focused on the energy transition, environmental protection and equality & inclusive growth.

We believe investing in the blue economy will help advance the fight against climate change and ensure that the oceans can continue to function as a sink for carbon emissions from human activity. Such investments are suited for investors with a long-term perspective, an interest in contributing to a greener future and making a positive impact.

In our view, finance can play a major role in pushing companies linked to the blue economy to improve their practices. Those investors who consider the preservation of marine resources as an absolute priority are set to see investment opportunities in companies that develop marine and ocean projects opening up as awareness of the blue economy’s appeal grows.


[1] According to Agence internationale de l’Énergie in futura-sciences.com 21/07/2020

[2] See energiesdelamer.eu 12/06/2020


Read more about sustainable investing


Any views expressed here are those of the author as of the date of publication, are based on available information, and are subject to change without notice. Individual portfolio management teams may hold different views and may take different investment decisions for different clients. This document does not constitute investment advice.

The value of investments and the income they generate may go down as well as up and it is possible that investors will not recover their initial outlay. Past performance is no guarantee for future returns.

Investing in emerging markets, or specialised or restricted sectors is likely to be subject to a higher-than-average volatility due to a high degree of concentration, greater uncertainty because less information is available, there is less liquidity or due to greater sensitivity to changes in market conditions (social, political and economic conditions).

Some emerging markets offer less security than the majority of international developed markets. For this reason, services for portfolio transactions, liquidation and conservation on behalf of funds invested in emerging markets may carry greater risk.

Let’s block ads! (Why?)


728x90x4
Source link
Continue Reading

Business

A timeline of events in the bread price-fixing scandal

Published

 on

 

Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.

Here’s a timeline of key events in the bread price-fixing case.

Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.

Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.

Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.

Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).

Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.

June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.

Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”

Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.

July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.

Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX composite up more than 250 points, U.S. stock markets also higher

Published

 on

 

TORONTO – Canada’s main stock index was up more than 250 points in late-morning trading, led by strength in the base metal and technology sectors, while U.S. stock markets also charged higher.

The S&P/TSX composite index was up 254.62 points at 23,847.22.

In New York, the Dow Jones industrial average was up 432.77 points at 41,935.87. The S&P 500 index was up 96.38 points at 5,714.64, while the Nasdaq composite was up 486.12 points at 18,059.42.

The Canadian dollar traded for 73.68 cents US compared with 73.58 cents US on Thursday.

The November crude oil contract was up 89 cents at US$70.77 per barrel and the October natural gas contract was down a penny at US2.27 per mmBTU.

The December gold contract was up US$9.40 at US$2,608.00 an ounce and the December copper contract was up four cents at US$4.33 a pound.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

Construction wraps on indoor supervised site for people who inhale drugs in Vancouver

Published

 on

 

VANCOUVER – Supervised injection sites are saving the lives of drug users everyday, but the same support is not being offered to people who inhale illicit drugs, the head of the BC Centre for Excellence in HIV/AIDS says.

Dr. Julio Montaner said the construction of Vancouver’s first indoor supervised site for people who inhale drugs comes as the percentage of people who die from smoking drugs continues to climb.

The location in the Downtown Eastside at the Hope to Health Research and Innovation Centre was unveiled Wednesday after construction was complete, and Montaner said people could start using the specialized rooms in a matter of weeks after final approvals from the city and federal government.

“If we don’t create mechanisms for these individuals to be able to use safely and engage with the medical system, and generate points of entry into the medical system, we will never be able to solve the problem,” he said.

“Now, I’m not here to tell you that we will fix it tomorrow, but denying it or ignoring it, or throw it under the bus, or under the carpet is no way to fix it, so we need to take proactive action.”

Nearly two-thirds of overdose deaths in British Columbia in 2023 came after smoking illicit drugs, yet only 40 per cent of supervised consumption sites in the province offer a safe place to smoke, often outdoors, in a tent.

The centre has been running a supervised injection site for years which sees more than a thousand people monthly and last month resuscitated five people who were overdosing.

The new facilities offer indoor, individual, negative-pressure rooms that allow fresh air to circulate and can clear out smoke in 30 to 60 seconds while users are monitored by trained nurses.

Advocates calling for more supervised inhalation sites have previously said the rules for setting up sites are overly complicated at a time when the province is facing an overdose crisis.

More than 15,000 people have died of overdoses since the public health emergency was declared in B.C. in April 2016.

Kate Salters, a senior researcher at the centre, said they worked with mechanical and chemical engineers to make sure the site is up to code and abidies by the highest standard of occupational health and safety.

“This is just another tool in our tool box to make sure that we’re offering life-saving services to those who are using drugs,” she said.

Montaner acknowledged the process to get the site up and running took “an inordinate amount of time,” but said the centre worked hard to follow all regulations.

“We feel that doing this right, with appropriate scientific background, in a medically supervised environment, etc, etc, allows us to derive the data that ultimately will be sufficiently convincing for not just our leaders, but also the leaders across the country and across the world, to embrace the strategies that we are trying to develop.” he said.

Montaner said building the facility was possible thanks to a single $4-million donation from a longtime supporter.

Construction finished with less than a week before the launch of the next provincial election campaign and within a year of the next federal election.

Montaner said he is concerned about “some of the things that have been said publicly by some of the political leaders in the province and in the country.”

“We want to bring awareness to the people that this is a serious undertaking. This is a very massive investment, and we need to protect it for the benefit of people who are unfortunately drug dependent.” he said.

This report by The Canadian Press was first published Sept. 18, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending